SCHEMBL9036759

SCHEMBL9036759

CCCCc1cn(C(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 8/20 0.54
AGTR2 P50052 7/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9554532 0.97 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9035297 0.94 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9036627 0.93 AGTR1 (0.52) AGTR1AGTR2
SCHEMBL9554614 0.91 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9553959 0.90 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9705099 0.90 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9553949 0.90 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9036561 0.90 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL7686341 0.90 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL7676455 0.90 AGTR1 (0.43) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0555331-B1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1996-04-24 EP claimed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US claimed
EP-0555331-B1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1996-04-24 EP disclosed
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed